RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST – Trademark Portfolio
Entity Type: 17
RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The owner is based in Mount Shasta, CA.
401 Berry Street
Mount Shasta, CA 96067
Showing of trademarks Trademarks
Trademark Classifications
RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST have?
RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST has 1 U.S. trademark filed with the USPTO.
What trademark classes does RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST file in?
RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST's trademark registration success rate?
RICHARD ANDERSON AND AVONA L' CARTTIER, BOTH U.S CITIZENS, AS THE TRUSTEES OF VISION INTERNATIONAL TRUST has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.